Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Seizure types Stories

2014-03-12 12:29:03

Qudexy(TM) XR Offers Newest Option for Managing Certain Seizure Disorders and Marks the Company's Entrance into the Epilepsy Therapeutic Area MAPLE GROVE, Minn., March 12, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced it received approval on March 11, 2014 from the U.S. Food and Drug Administration (FDA) for Qudexy(TM) XR (topiramate) extended-release capsules, a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth...

2014-02-21 11:36:15

Two new smart phone applications may help people detect epileptic seizures and get better stroke treatment, according to two studies released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014. In the first study, an epilepsy app was designed to help non-doctors determine if a person is having an epileptic seizure. "It can often be difficult to determine whether someone is having an epileptic seizure," said...

2014-01-31 23:33:53

“Psychogenic Non-Epileptic Seizures: A Guide” by Lorna Myers, Ph.D. provides readers with clear explanations about this serious psychological condition as well as tools to get back to a healthy life. New York, NY (PRWEB) January 31, 2014 Psychogenic Non-epileptic Seizures (PNES) can have devastating effects on those who develop it . PNES is a serious psychological condition that is still not well understood by doctors or the public. These seizures look very much like epileptic...

2013-12-06 00:20:48

SILVER SPRING, Md., Dec. 6, 2013 /PRNewswire-USNewswire/ -- A new white paper from the Tuberous Sclerosis Alliance (TS Alliance), entitled "Vigabatrin-Associated Visual Field Loss (VAVFL): What You Need to Know," was released today at the American Epilepsy Society annual meeting in Washington, DC. The white paper was written by Darcy A. Krueger, MD, PhD, Associate Professor, Clinical Pediatrics and Neurology, Tuberous Sclerosis Clinic, Cincinnati Children's Hospital. Vigabatrin is...

2013-11-23 23:00:06

Malichi Bell from Jacksonville, FL, had surgery at Wolfson Children's Hospital to disconnect the left side of his brain from the right to stop seizures that were leading to serious injuries. (PRWEB) November 24, 2013 Christina Bell and her husband Troy didn’t suspect anything was wrong with their newborn son when he was born in 2005. Not until he was 9 months old when, while in the care of Troy’s grandmother, Malichi had his first seizure and began convulsing. “I had just left...

2013-11-18 08:30:03

Multiple Presentations Highlight Findings from Phase 3 Trial Investigating USL255 for Adjunctive Treatment of Epilepsy in Patients with Refractory Partial-Onset Seizures MAPLE GROVE, Minn., Nov. 18, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that it will present new research from its epilepsy clinical development program for USL255 (extended-release topiramate) during the American Epilepsy Society's (AES) 67(th) Annual Meeting in Washington, DC,...

2013-11-01 08:27:55

Findings Presented at 42nd Annual Child Neurology Society Meeting MAPLE GROVE, Minn., Nov. 1, 2013 /PRNewswire/ -- A new systematic review found that when compared with intravenous or rectally administered diazepam, intranasal midazolam was equally effective and demonstrated comparable safety for the treatment of acute seizure emergencies in pediatric patients. Findings from the systematic review were presented at the 42(nd) Annual Child Neurology Society meeting in Austin, Texas, October 30...

2013-07-17 11:09:29

Researchers at Bonn University Hospital and at the MPI Cologne predict chances of success of an operation Scientists at Bonn University Hospital and at the Max Planck Institute for neurological research in Cologne have developed a method with which the chances of success of a surgical procedure for temporal lobe epilepsy can be accurately predicted. The rate of accurate predictions is more than 90%. The results are now being presented in the scientific journal "NeuroImage:Clinical."...

2013-06-24 08:28:48

Extension Study Offers Patients Experiencing Seizure Clusters Continued Access to USL261 MAPLE GROVE, Minn., June 24, 2013 /PRNewswire/ -- Upsher-Smith Laboratories, Inc., (Upsher-Smith) today announced that it is enrolling patients in its open-label safety extension study to ARTEMIS1 (Acute Rescue Therapy in Epilepsy with Midazolam Intranasal Spray), a global Phase III clinical trial for USL261, a novel, investigational formulation of the benzodiazepine midazolam. USL261 is...

2013-06-18 08:29:16

- Golfer is the first to take online Pledge, an outlet for epilepsy patients and caregivers to take action and ask themselves, "Am I really okay?" ATLANTA, June 18, 2013 /PRNewswire/ -- regulated information -- Global biopharmaceutical company UCB, Inc. and professional golfer Jeff Klauk today announced the launch of a new Pledge campaign for people with epilepsy and their loved ones. The Pledge empowers the millions of Americans living with epilepsy to take a stand and make a...